Frontrunner Amgen Expects US Biosimilars To ‘Shift Significantly’ With Adalimumab

Firm Prepares To Launch First Humira Biosimilar At A ‘Pivotal Time’ For The US Market

Paradigm Shift Sign
Humira biosimilars will shift the US market significantly • Source: Shutterstock

More from Biosimilars

More from Products